Natural products as Nrf2 modulators for ferroptosis inhibition in renal disease therapy: Recent progress and future

Ruimin Tian1, Shan Guo2, Shudong Chen2

  • 1State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau 999078, China; The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China.

Abstract

Insights

Natural products that regulate Nrf2 (nuclear factor erythroid 2-related factor 2) can inhibit ferroptosis, offering protective effects against various renal diseases. This review highlights these natural products for potential kidney disease therapies.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology
  • Nephrology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular processes including redox balance and inflammation.
  • Nrf2 plays a critical role in ferroptosis and the pathogenesis of renal diseases.
  • A comprehensive overview of natural products targeting Nrf2-related ferroptosis in renal diseases is needed.

Purpose of the Study:

  • To review the therapeutic potential of natural products that modulate Nrf2-related ferroptosis in the context of renal diseases.
  • To consolidate current knowledge on the protective effects of these natural products against kidney conditions.

Main Methods:

  • Systematic literature search across major scientific databases (PubMed, Web of Science, Google Scholar, CNKI, Wanfang, VIP).
  • Keywords included Nrf2, ferroptosis, natural products, phytochemicals, and various renal disease terms.
  • Comprehensive exploration of research on Nrf2, ferroptosis, and natural product interventions in kidney diseases.

Main Results:

  • Ferroptosis is implicated in diverse renal diseases such as acute kidney injury, diabetic nephropathy, and renal fibrosis.
  • Nrf2 regulates genes involved in iron, antioxidant, and lipid metabolism, thereby influencing ferroptosis.
  • Over twenty natural products demonstrate renoprotective effects by inhibiting ferroptosis through Nrf2 modulation.

Conclusions:

  • Natural products acting as Nrf2 modulators offer therapeutic benefits by inhibiting ferroptosis in renal diseases.
  • This review provides insights for developing novel therapeutic strategies and drug discovery for kidney diseases.
  • Further research and development of natural products for renal disease treatment are warranted.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K